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Abstract
A C1858T (R620W) variation in the PTPN22 gene encoding the tyrosine phosphatase LYP is a major risk factor for human
autoimmunity. LYP is a known negative regulator of signaling through the T cell receptor (TCR), and murine Ptpn22 plays a
role in thymic selection. However, the mechanism of action of the R620W variant in autoimmunity remains unclear. One
model holds that LYP-W620 is a gain-of-function phosphatase that causes alterations in thymic negative selection and/or
thymic output of regulatory T cells (Treg) through inhibition of thymic TCR signaling. To test this model, we generated mice
in which the human LYP-W620 variant or its phosphatase-inactive mutant are expressed in developing thymocytes under
control of the proximal Lck promoter. We found that LYP-W620 expression results in diminished thymocyte TCR signaling,
thus modeling a ‘‘gain-of-function’’ of LYP at the signaling level. However, LYP-W620 transgenic mice display no alterations
of thymic negative selection and no anomalies in thymic output of CD4+Foxp3+ Treg were detected in these mice. Lck
promoter-directed expression of the human transgene also causes no alteration in thymic repertoire or increase in disease
severity in a model of rheumatoid arthritis, which depends on skewed thymic selection of CD4+ T cells. Our data suggest
that a gain-of-function of LYP is unlikely to increase risk of autoimmunity through alterations of thymic selection and that
LYP likely acts in the periphery perhaps selectively in regulatory T cells or in another cell type to increase risk of
autoimmunity.
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Introduction
The PTPN22 gene, encoding the lymphoid tyrosine phosphatase
LYP, has emerged as one of the major non-HLA risk factors for a
wide range of autoimmune diseases, including type 1 diabetes,
rheumatoid arthritis (RA), systemic lupus erythematosus, Graves’
disease and others [1,2]. A missense C1858T single nucleotide
polymorphism in exon 14 of the PTPN22 gene leads to LYP-
R620W substitution. The variant PTPN22 allele confers to carriers
a roughly two-fold increased risk of autoimmunity [2–5]. LYP
inhibits signaling through the T cell receptor (TCR), and its
substrates in T cells include the phosphorylated tyrosine residues
in the activation motifs of Lck, Zap-70 and other signaling
molecules [4,6–8]. Mice made deficient for Ptpn22 (encoding Pep,
the murine LYP-homolog PEST-enriched phosphatase) display a
phenotype of increased TCR signaling in effector T cells, which
correlates with an expansion of the effector-memory T cell
compartment [9,10]. The LYP-R620W substitution impairs the
ability of the phosphatase to bind to the SH3 domain of the C-
terminal Src-family kinase CSK [3,4], which is a major LYP
interactor in T cells [7,11]. LYP-W620 also displays 1.5–2 fold
increased intrinsic phosphatase activity compared to the common
R620 variant [12–14].
Studies of the effect of the LYP-R620W substitution on immune
cell signaling have not yet yielded a unifying model. We and others
reported that TCR signaling is impaired in T cells from patients
with autoimmune disease who carry the LYP-W620 variant
[12,15–17]. Reduced signaling through antigen receptors has also
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been reported in B cells and peripheral blood mononuclear cells
(PBMC) of both patient and healthy donor LYP-W620 carriers
[13,15,18]. Together, these findings suggest that the LYP-W620
variant is a ‘‘gain-of-function’’ negative regulator of antigen
receptor signaling.
Several models have been proposed to explain the gain-of-
function phenotype, including increased phosphatase activity
following reduced CSK-mediated phosphorylation of the regula-
tory Tyr536 residue [14], and increased recruitment of the LYP-
W620 variant to lipid rafts following release from cytoplasmic
sequestration by Csk [19]. However, others have proposed an
opposing model wherein the R620W substitution confers ‘‘loss-of-
function’’ effects on antigen receptor signaling. Supporting data
for a LYP-W620 ‘‘loss-of-function’’ hypothesis come from
overexpression experiments in Jurkat T cells [20]. Enhanced
TCR-driven calcium mobilization was observed in human LYP-
W620 carriers and in T cells from a mouse carrying a knock-in
R619W mutation in mouse Pep that is homologous to the human
LYP R620W variation [21]. Chang et al. identified a new
dominant-negative isoform of LYP and proposed a model that
reconciles ‘‘gain-of-function’’ and ‘‘loss-of-function’’ observations
[22]. Dai et al. recently reported a phenotype of enhanced TCR
signaling and spontaneous autoimmunity in R619W knock-in
mice [23]. Analysis of the spectrum of phosphorylated molecules
in TCR-stimulated Pep-R619W T cells suggested altered enzy-
matic specificity [23]. In line with this ‘‘altered function’’ model, a
recent analysis of peripheral T cells from genotyped healthy
subjects suggested that the LYP-R620W mutation can positively or
negatively affect TCR signaling, depending on the biochemical
readout assayed and on the stage of signaling [24].
A prevailing model of thymocyte selection holds that TCR
affinity for MHC/peptide ligand plays a central role in shaping the
peripheral TCR repertoire [25]. Deletion of autoreactive thy-
moyctes and agonist selection of regulatory T cells (Treg) are two
important mechanisms for establishing T cell tolerance that
depend upon high-affinity interactions between TCR and ligand.
Phenotyping of Ptpn22 knockout mice suggested that Pep might
play a role in regulating thymic selection. Increased positive
thymic selection has been reported in Ptpn22 KO mice [9] and in
two independently-generated Pep R619W knock-in mouse mod-
els, one of which developed spontaneous autoimmunity [21,23].
Increased negative selection of H-Y transgenic male thymocytes
mice was reported in one Pep R619W knock-in model [23], but
thymic deletion was not altered in the other Pep R619W knock-in
strain [21] or in Ptpn22 KO mice [9]. We reported increased TCR
signaling in Ptpn22 KO thymocytes, correlating with increased
thymic output of Treg in KO mice [26]; however, another group
found no difference in thymic Treg percentages in an indepen-
dently generated KO model [23]. The potential effect of the
autoimmune-associated human LYP-W620 variant in thymic
selection has not yet been examined in a controlled genetic
environment (congenic mice). Yeh et al. recently reported that
overexpression of wild type Pep under control of the distal Lck
promoter did not result in alteration of thymocyte numbers in the
NOD background [27], however the distal Lck promoter is
expressed only in late stages of thymocyte selection [28], and the
effect of the autoimmune-predisposing R620W variant was not
assessed.
In this study, we addressed effects of the human LYP-W620
variant on thymocyte signaling and selection by expressing the
variant phosphatase under control of the proximal Lck promoter.
To model effects of altered enzymatic activity inherent in LYP-
W620, we studied mice exhibiting low overexpression levels of the
active human phosphatase in thymocytes. To detect possible
effects unrelated to the increased phosphatase activity, we also
examined animals overexpressing an enzymatically-inactive mu-
tant (C227S) of the LYP-W620 phosphatase. Mice transgenic for
the active phosphatase displayed reduced thymocyte TCR
signaling when compared to mice transgenic for the inactive
phosphatase or to non transgenic littermates. However no
significant alterations of T cell selection or of thymic Treg output
were observed in LYP-W620 transgenic mice. Our study suggests
that the reported gain-of-function activity of LYP-W620 is
insufficient to significantly alter thymic output; thus it is unlikely
that its major disease-predisposing role is exerted during thymo-
cyte selection.
Materials and Methods
Mouse Experimental Work
Generation of ProxLck-driven transgenic mice. cDNAs
encoding either N-terminal HA-tagged LYP-W620 (LYPW) or its
inactive C227S mutant (LYPWC227S) were cloned into the BamHI
site of the p1017 vector [29](obtained from T. Mustelin, Sanford-
Burnham Medical Research Institute). The transgenes were
isolated from the vector backbone by digestion with NotI, and
pronuclear oocyte injection was performed using fertilized ova
from C57BL/6 (B6)D2F1 females, and pseudopregnant outbred
ICR females as foster mothers. Genotyping of transgenic founders
and all transgenic animals was performed by PCR, using one
primer 59-tgtgaacttggtgcttgagg-39 on the Lck promoter and
another 59-tgttatggcatgcatggagt-39 on the LYP cDNA. All founder
animals were bred with C57BL/6Tac mice and germline
transmission was obtained from three B6D2F1-Tg(LckproxLYP-
W620)/Igm founders and two B6D2F1-Tg(LckproxLYP-W620/
S227)/Igm founders. Lines were generated from each of the
founders carrying the transgenes in hemizygosity. Each line was
tested for expression of the transgene and activity of the transgenic
phosphatase. The two founder lines B6D2F1-Tg(LckproxLYP-
W620)958/Igm (here abbreviated as TgLYPW) and B6D2F1-
Tg(LckproxLYP-W620/S227)963/Igm (here abbreviated as
TgLYPWC227S) were selected for further studies and extensively
backcrossed onto the BALB/c background for .15 generations
before breeding with Skg mice (see below).
Generation of BAC-transgenic mice. Recombineering
(homologous recombination in bacteria) [30] was used to
introduce the autoimmune-associated variant (PTPN22-C1858T)
into the human PTPN22 locus. A 200 kb Bacterial Artificial
Chromosome (BAC; Invitrogen) fragment of human genomic
DNA containing the entire PTPN22 locus, including 60 kb located
59 to the PTPN22 transcriptional start site, was used as a template.
Following recombineering, 116 kb NotI restriction fragments
encoding the disease variant LYP-W620 protein was used for
pronuclear B6 oocyte injection and generation of founder mice
(BACLYPW) directly on B6 background as described above. LYP
expression in BACLYPW mice has been described elsewhere [31].
Skg mice and arthritis scoring. Skg mice were kindly
provided by S. Sakaguchi (Kyoto University, Kyoto, Japan). Skg/
Skg mice are homozygous for a loss-of-function W163C mutation
of Zap-70 that leads to decreased thymic TCR signaling and
altered selection of self-reactive CD4+ T cells and of Treg [35,36].
These mice display alterations of the Vb thymic repertoire and
develop spontaneous arthritis on the BALB/c background
[35,37,38], whose frequency and clinical course is dependent on
microbial colonization and on cleanliness of the environment.
However severe arthritis can be induced in all Skg/Skg mice,
independent on their microbial colonization, by intraperitoneal
injection with fungal wall polysaccharides, including zymosan and
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mannan [39,40]. In the La Jolla Institute for Allergy &
Immunology (LJI) animal facility, Skg/Skg animals developed
spontaneous arthritis with very low frequency and the severity of
arthritis was variable among cages. However all Skg/Skg mice
developed severe arthritis after intraperitoneal injection of 20 mg
mannan (purchased from Sigma) dissolved in 200 ml PBS. Skg/
WT heterozygous mice display altered thymic selection [36,37]
and alterations of the Vb thymic repertoire [37] qualitatively
similar to the ones found in Skg/Skg mice, however they do not
develop spontaneous [35] or polysaccharide-induced (our unpub-
lished observation) arthritis. Clinical scoring of arthritis was
carried out as described [35].
Other mouse models. Foxp3GFP mice were kindly provided
by A. Rudensky (Sloan-Kettering Institute, NY) [32]. HY-TCR
mice [33] were kindly provided by H. Cheroutre (La Jolla Institute
for Allergy and Immunology, CA), or by K. Hogquist (University
of Minnesota; for the crosses with BACLYPW mice), and Vb5
TCRbonly transgenic mice by P. Fink (University of Washington,
WA). BALB/c and DO11.10 mice [34] were purchased from
Taconic and Rip-mOva and OT-1 mice from Jackson laborato-
ries. Ptpn22-deficient mice were kindly provided by A. Chan
(Genentech).
Bone marrow chimeras and infections with Lm-Ova and
VSV-Ova. Recipient mice were lethally irradiated with 900 rad
and one day later engrafted with bone marrow cells isolated from
the femur and tibia. Prior to injection, the bone marrow was T cell
depleted by incubating cells with biotinylated anti-CD3 antibody
(eBiociences), anti-biotin microbeads followed by magnetic sepa-
ration in LS columns (all Miltenyi Biotec, Bergisch-Gladbach,
Germany). Mice were treated with antibiotics (Bactrim, Roche)
until 3 weeks post-irradiation.
Frozen stocks of recombinant, ovalbumin expressing Listeria
monocytogenes [Lm-Ova] were grown in brain-heart infusion broth
(Oxoid, UK) to mid log phase. Bacterial numbers were determined
by measuring the OD at 600 nm. 1000–3000 cfu were injected in
PBS intravenously. Vesicular stomatitis virus expressing Ova (VSV-
Ova) [41] were grown and titered on BHK cells. Frozen stocks
were diluted in PBS to 26106 pfu and injected intravenously.
Ex vivo Thymocyte or T cell Stimulation
Spleen and thymus cell suspensions were obtained by mashing
the organs through a 100 mm nylon cell strainer (BD Falcon). Red
blood cells were lysed with a hypotonic ACK lysis buffer. 56105
CD45.1 congenic thymocytes were co-cultured in 96 well plates
for 18–22 hours with 7.56104 irradiated RMA cells and titrated
doses of SIINFEKL, SIITFEKL, or SIIVFEKL peptide (EMC
Microcolelctions, Tu¨bingen, Germany). Cultures were stained
with anti-CD8 (53–6.7, PerCP, eBioscience), CD45.1 (clone A20),
CD4 (GK1.4) purchased from BioXcell (West Lebanon, NH) and
conjugated to FITC or A647 using labeling reagents from
Invitrogen.
To identify Kb/Ova reactive T cells in infected mice, up to
46106 total splenocytes were seeded into 96 well plates. The cells
were stimulated with titrated doses of SIINFEKL peptide for
30 min at 37uC, then 7 mM Brefeldin A (Sigma) was added and
the cells were returned to 37uC for another 4.5 hours.
Afterwards, the cells were washed, incubated for 30 min at 4uC
in PBS supplemented with 2% FBS and 0.01% azide (FACS
buffer) and then stained with the following antibodies: anti-CD8
PerCP-Cy5.5 (clone 53–6.7, eBioscience), anti-CD4 and anti-IFNc
(BioXcell, self-conjugated to FITC, Invitrogen). Then the cells
were fixed and permeabilized using the Cytofix/Cytoperm Kit
(BD, Franklin Lakes NJ, USA) and stained with anti-IFNc
(BioXCell, self-conjugated to Alexa Fluor 647, Invitrogen). Data
were analyzed with FlowJo software (Tree Star Inc). Graphs were
prepared and EC50 concentrations were determined with
GraphPad Prism.
Stimulation for the CD69 expression assay was performed by
precoating 96-well plates with 10 mg/ml and 25 mg/ml anti-CD3
overnight at 4uC and then culturing thymocytes at 26105 cells/
well for 18 h at 37uC.
Phospho-Erk (pErk) ELISA
pErk levels were detected by ELISA using the PathScanH
Phospho-p44 MAPK (Thr202/Tyr204) Sandwich ELISA anti-
body pair (Cell Signaling Technology) according to manufactur-
er’s protocols.
FACS Analyses and Intracellular Staining (ICS)
Abs (conjugated to eFluor450, Pacific Blue, APC, PE, FITC,
PE-Cy7, PerCP-Cy5.5, PerCP-eFluor710, V500 and Alexa-
Fluor700) directed against the following surface markers were
obtained from eBioscience, BD PharMingen, BioLegend, Proim-
mune and used at a 1/100 dilution to analyze immune cell subsets
in single cell suspensions of thymi and lymph nodes of LYP Tg
mice: CD3e (145-2C11), CD4 (GK1.5), CD8a (53-6.7), CD25
(PC61.5), CD44 (IM7), CD69 (H1.2F3), B220/CD45R (RA3–
6B2), Vb3 (KJ25), Vb5.1/5.2 (MR 9-4), Vb8.1, 8.2 (KJ16),
DO11.10 TCR (KJ1-26), HY TCR (T3.70), CD1d tetramers. For
intracellular cytokine staining [40], lymph node (LN) cells were
stimulated with 20 ng/ml PMA and 1 mM ionomycin in the
presence of GolgiStop (BD Biosciences) for 5 h. Cells were then
stained for surface antigens, fixed, and permeabilized using
Cytofix/Cytoperm buffer (BD Biosciences), followed by anti-IL-
17 (BD Pharmingen) staining. To detect low level expression of
HA-tagged LYP by ICS indirect immunofluorescence was used to
increase sensitivity. Thymocytes were first stained for surface
markers followed by fixation and permeablization. Cells were then
stained with an anti-HA Ab (Cell Signaling Technology) for 1 hour
followed by washing and staining with FITC-conjugated anti-
rabbit Ab (BD PharMingen). For pErk ICS, cells were stimulated
with 10 mg/ml anti-CD3 for 20 min, followed by fixation in 4%
paraformaldehyde. After washing, cells were permeabilized with
90% methanol at 4uC, then stained with anti-phospho-p44/42
MAPK (Erk1/2) (Cell Signaling Technology) followed by washing
and staining with FITC-conjugated anti-rabbit Ab (BD Pharmin-
gen). All flow cytometry experiments were performed using an
LSRII (BD Bioscience) and data was analyzed using FlowJo
Software (Tree Star).
Immunoprecipitations
For immunoprecipitations (IPs), cells were lysed in 20 mM
Tris/HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA with 1%
Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml
aprotinin, 10 mg/ml leupeptin and 10 mg/ml soybean trypsin
inhibitor. Lysates were probed with the indicated antibodies for
2 h at 4uC, followed by incubation with PGSepharose beads (GE
Healthcare) for 1 h at 4uC. Beads were then washed in lysis buffer,
and proteins were eluted in Laemmli sample buffer (Bio-Rad).
Quantitative PCR (qPCR)
Total human PTPN22 and mouse Ptpn22mRNA expression was
measured by quantitative real-time RT-PCR (qPCR) using specific
primers designed to amplify the human and mouse mRNAs. Total
RNA was isolated using the RNeasy Plus Micro Kit (Qiagen).
After DNase treatment of the RNA with AmbionH TURBOTM
DNase (Life Technologies), cDNA was reverse transcribed using
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the SuperScriptH III First-Strand Synthesis System (Life Technol-
ogies). Gene expression was quantified using SYBR Green
reaction mixture (SaBiosciences/Qiagen) on a LightCycler 480
(Roche) with a cycling program of 94uC for 3 minutes, 35 cycles of
(94uC for 45 seconds, 62uC for 30 seconds, 72uC for 1 minute),
72uC for 10 minutes. Reactions were performed in triplicate and
normalized to the mouse housekeeping gene RNA Polymerase II
(Polr2a). Primer sequences were:
PTPN22 forward 59-GAATTTCTGAAGCTGAAAAGGCA-
39
PTPN22 reverse 59-TCCCAAATCATCCTCCAGAAGTC-39
Polr2a forward 59 CCAGGAAACACATTGCGTC-39
Polr2a reverse 59-GGAAGAAGAACTCAGTGGGTG-39.
Phosphatase Assays
Phosphatase assays were performed on HA-tagged LYP
following anti-HA-IPs from thymocytes from the indicated mice.
Cells were lysed in 50 mM HEPES, pH 7.4, 150 mM NaCl,
5 mM EDTA with 1% Triton-X 100, 1 mM phenylmethylsulfo-
nyl fluoride, 10 mg/ml aprotinin, 10 ml/ml leupeptin, and 10 mg/
ml soybean trypsin inhibitor. The IPs were washed in 50 mM Bis-
Tris, pH 6.0, and then resuspended in phosphatase buffer (50 mM
Bis-Tris, pH 6.0, 5 mM DTT, 0.005% Tween-20, 5 mM sodium
fluoride, 2 mM sodium pyrophosphate). After the addition of
0.1 mM 6,8-Difluoro-4-Methylumbelliferyl Phosphate (DiFMUP,
Life Technologies), the reaction was monitored continuously by
measuring the increase in fluorescence (lex = 340 nm and
lem= 460 nm) at 60 s intervals for 30 min using a Tecan Infinite
M1000 plate reader (Tecan) [42]. The activity measured in
triplicate was corrected for the nonspecific signal of identical
reactions performed also in triplicate without the addition of
enzyme.
Ethics statement. This study was carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the institutional Animal
Use Committees of the University of Southern California
(Protocols #19853 and #10714), the La Jolla Institute for Allergy
and Immunology (Protocol #AP140-NB4), the University of
Minnesota (Protocol #1106A00402) or the veterinarian author-
ities of the Swiss Canton Vaud (Protocols 2253 and 2643). All
efforts were made to minimize animal suffering.
Results
Generation of Mice Carrying Thymic Overexpression of
LYP-W620
In order to assess the effect of LYP-W620 overexpression at the
thymic level, we generated transgenic mouse lines overexpressing
N-terminal HA-tagged LYPW (abbreviated as TgLYPW) or its
inactive mutant LYPWC227S (abbreviated as TgLYPWC227S)
under the control of the proximal Lck promoter. The Lck proximal
promoter is highly active in thymocytes, including immature
double negatives (DN), double positives (DP), and CD4+ and
CD8+ single positives (SP) [29], but is repressed after thymocyte
emigration. Fig. 1A shows that the two transgenic constructs were
expressed in thymocytes, although at different levels. Progeny of
an additional independent founder expressing TgLYPWC227S all
displayed overexpression levels several orders of magnitude higher
than those observed in the TgLYPW line expressing the active
phosphatase (data not shown). A single TgLYPWC227S founder
line was selected for all further analyses. In line with known
thymus-specific activity of the proximal Lck promoter, no
expression of the transgenes was detectable in the spleen and
lymph nodes of the transgenic mice (data not shown). The
transgene-encoded LYP-W620 protein was active in an in vitro
phosphatase assay, while as expected, LYP-W620/S227 was
completely inactive (Fig. 1B). The highest expression of the
transgenic protein was achieved in DP thymocytes, although
overexpression was evident in SP and DN cells (Fig. 1C and
Fig. 1D). An analysis at the mRNA level using primers that cross-
react with endogenous Ptpn22 suggested that thymocytes from the
TgLYPW line carry an average two-fold overexpression of
PTPN22 transcript (Fig. 1E).
Thymic Overexpression of LYPW Leads to Reduced
Thymocyte TCR Signaling
The gain-of-function model predicts that LYP-W620 will exert
augmented negative regulatory function in antigen receptor
signaling. We therefore assessed whether overexpression of LYPW
results in decreased thymocyte TCR signaling. Fig. 2A and
Fig. 2B show that Erk phosphorylation after engagement of the
TCR was reduced in thymocytes from TgLYPW transgenic
animals compared to cells from non transgenic littermates.
Notably, despite exhibiting significantly higher expression of
LYP protein compared to TgLYPW mice (Fig. 1A),
TgLYPWC227S transgenic thymocytes displayed no alteration in
Erk phosphorylation compared to non transgenic cells. Similarly,
TCR-dependent CD69 upregulation was reduced on DP thymo-
cytes from TgLYPW, but not from TgLYPWC227S, transgenic
mice, compared to their respective littermates (Fig. 2C). Overall,
these data indicate that thymocyte-expressed LYP-W620 can
repress TCR signaling in total thymocytes and in DP thymocytes
in particular, and suggest that modulation of TCR signaling by
LYP-W620 is phosphatase-activity dependent.
Thymic Overexpression of LYPW does not Affect Positive
or Negative Selection or the Output of Thymic
CD4+Foxp3+ Treg
Loss of Pep results in increased numbers of both CD4SP and
CD8SP thymocytes, but no defects in negative selection [9,21].
We asked whether thymocyte expression of LYP-W620 could
modulate positive or negative selection. We found no significant
alterations in the total thymocyte numbers and numbers of DN,
DP, CD4SP, CD8SP, NKT or gamma-delta T cells associated
with TgLYPW or TgLYPWC227S expression (Table 1). Further,
we observed no differences in the percentages of CD4+Foxp3+ Treg
present in the thymi of TgLYPW or TgLYPWC227S mice (data not
shown). To further determine whether CD4+Foxp3+ Treg thymic
output is affected by the expression of the LYPW transgene, we
bred the transgenic mice with GFP-Foxp3 mice carrying a GFP
cassette knocked into the Foxp3 locus [32]. Fig. 3A shows that the
frequency of GFP-Foxp3+ thymocytes was unaffected by the
expression of the LYPW transgene. To address the roles of LYP-
W620 and of LYP enzymatic activity in TCR-driven thymocyte
development, we bred the transgenic mice to DO11.10 and H-Y
TCR transgenic strains that served as models of positive and
positive/negative selection, respectively. Fig. 3B shows that the
numbers of DO11.10 TCR transgenic cells were not affected by
expression of the LYPW or LYPWC227S transgenes pointing to the
absence of anomalies of positive selection in these mice. As shown
in Fig. 3C, total numbers of transgenic HY-TCR thymocytes
were unaffected by the expression of the active phosphatase in F1
B6xBALB/c male mice. In this model, deletion of the HY-TCR
transgene was minimal, likely due to the B6xBALB/c genetic
background, however no skewing of the percentages of DP,
CD8SP or CD4SP could be found, suggesting that negative
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selection of CD8+ cells operates normally in these mice (Fig. 3C).
Similarly, we did not see any differences between non transgenic
and TgLYPW OT-1 TCR transgenic mice in the efficiency of
CD8+ negative selection upon crossing the animals to cognate
antigen-expressing Rip-mOva mice (data not shown).
The above studies of negative selection were carried out in F1
B6xBALB/c mice in which overexpression or mis-expression of
Lck promoter-directed LYP-W620 might obscure phosphatase-
dependent changes in TCR-dependent thymocyte development.
Therefore, we sought independent confirmation of our findings by
carrying out studies of animals made transgenic for human
PTPN22 on a pure B6 background. Mice bearing an entire
PTPN22-*T1858 human regulon encoding a LYP-W620 protein
were generated on a B6 background under the supposition that
endogenous PTPN22 transcriptional regulatory elements would
induce physiologic spatio-temporal expression patterns. To mimic
the LYP-W620 phosphatase allele ‘‘load’’ observed in the most
common human carrier state (heterozygosity for one allele each of
LYP-R620 and LYP-W620), we bred the animals with Ptpn22-
deficient mice to generate Pep+/2.LYP-W620 (abbreviated as
BACLYPW) mice. A non-significant trend toward a decrease in
the total number of thymocytes was observed in BACLYPW mice
compared to non transgenic littermate mice. We observed no
differences between Pep+/2 littermates and BACLYPW transgenic
mice in thymocyte number or distribution (Fig. 4A and data not
shown). These findings provided further evidence that LYP-W620
expression does not cause grossly altered thymic development.
Figure 1. Mice transgenic for LYP-W620 (TgLYPW) show overexpression of LYP in DP thymocytes. A, LYP protein expression in TgLYPW
thymocytes. Total thymocytes from TgLYPW (lane 2) or a non-Tg littermate (lane 1) and TgLYPWC227S (lane 4) or a non-Tg littermate (lane 3) were
lysed and subjected to immunoprecipitation (IP) using an anti-HA antibody (Ab). Panel shows Western blotting using an anti-LYP Ab. Data are
representative of 3 independent experiments with similar results. B, LYP phosphatase activity in TgLYPW thymocytes. Anti-HA IPs were performed
from lysates of total thymocytes from TgLYPW and TgLYPWC227S mice. Graphs show the phosphatase activity of LYP as assessed by
dephosphorylation of the fluorescent substrate DiFMUP. Data are representative of 2 independent experiments with similar results. C–D, LYP-W620
transgene expression in thymocyte subpopulations. Expression of LYPW (C) or LYPWC227S (D) was assessed by intracellular staining using a
fluorophore-conjugated anti-HA Ab in DN (upper left panel), DP (upper right panel) CD4SP (lower left panel) and CD8SP (lower right panel)
thymocytes from Tg mice (black graphs) and control non-Tg littermates (grey filled graphs). E, Quantification of overexpression of LYPW relative to
endogenous Pep in DP thymocytes of TgLYPW mice. mRNA encoding LYP and Pep was quantified by qPCR from sorted DP thymocytes from control
BALB/c (white bar) and TgLYPW (striped bar) mice, using a primer pair that amplifies both human PTPN22 and mouse Ptpn22 mRNAs. Graph shows
relative expression levels of total PTPN22 after normalization to the mouse housekeeping gene Polr2a. Data are average and SE of 3 biological
replicates.
doi:10.1371/journal.pone.0086677.g001
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We also asked whether endogenous promoter-driven LYP-
W620 expression affects thymocyte positive or negative selection.
We bred BACLYPW mice to H-Y TCR transgenic mice. H-Y
TCR transgenic female thymi displayed no significant differences
between BACLYPW and non transgenic Pep+/2 in total
thymocyte numbers or the distribution of H-Y TCR-high cells
(Fig. 4B and data not shown). A small decrease in the total
number of thymocytes was noticed in BACLYPW vs control male
HY-TCR transgenic mice (Fig. 4C). However, the distribution of
the major thymocyte subpopulations remained unaffected in
BACLYPWxHY-TCR male mice, compared with age-matched
controls (Fig. 4C). Together, these data supported the suggestion,
first raised by findings in TgLYPW animals (Fig. 3A), that LYP-
W620 does not differentially regulate thymocyte positive selection.
Significantly, the data from H-Y males suggest that if LYP-W620
does modulate negative selection, it does not impair that process.
Rather, the presence of human promoter-controlled LYP-W620
may serve to promote deletion of autoreactive thymocytes.
We reasoned that the DO11.10 and HY TCR transgenic
models might be inadequate to assess the effect of the R620W
mutation on thymic selection if a sufficiently intense stimulation of
the TCR is able to overcome the inhibitory effect of the R620W
gain-of-function on signaling. We therefore also utilized altered
peptide ligands to test how the R620W variant impacts negative
selection in a qualitative and quantitative manner. We co-cultured
non transgenic, TgLYPW, and TgLYPWC227S OT-1 thymocytes
with irradiated target cells and increasing concentrations of either
native OT-1 peptide (SIINFEKL, N4) or altered peptide ligands
Figure 2. Overexpression of LYPW inhibits TCR signaling in DP thymocytes. A–B, Overexpression of LYPW causes reduced activation of Erk
in thymocytes. Total thymocytes from TgLYPW or TgLYPWC227S (striped bars) or their respective non-Tg littermates (white bars) were stimulated with
20 mg/ml anti-CD3 and 10 mg/ml anti-Armenian Hamster IgG1 crosslinker for 2.5 minutes. A, Graph shows phosphorylation of Erk in total thymocyte
lysates assessed using the PathScanH phospho-p44 MAPK (Thr202/Tyr204) sandwich ELISA kit. Histogram shows mean and range of fold induction of
at least 3 biological replicates. B, Phosphorylation of Erk in DP thymocytes was assessed by phosphoflow analysis after intracellular staining with an
anti-pErk Ab. Fold induction of Erk phosphorylation was normalized within each experiment relative to the sample with the highest induction.
Histogram shows mean and range of at least 3 biological replicates. C, Overexpression of LYPW causes reduced T cell activation in DP thymocytes.
Thymocytes from TgLYPW or TgLYPWC227S (grey graphs) and their respective non-Tg littermates (black graphs) were cultured in the presence of
10 mg/ml (long dashed graphs) or 25 mg/ml (solid graphs) anti-CD3, or media alone (dotted graphs), for 18 hours. Graphs shows expression of CD69
in DP thymocytes as assessed by flow cytometry analysis after staining with an anti-CD69 Ab. Median fluorescence intensity (MFI) values are indicated
on each graph. Graphs are representative of at least 3 biological replicates with identical results.
doi:10.1371/journal.pone.0086677.g002
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(SIITFEKL, T4 and SIIVFEKL, V4). The latter peptides provide
a much lower level of stimulation to OT-1 T cells than SIINFEKL
[43]. Exposing double positive thymocytes to a stimulating peptide
causes a strong down-regulation of CD4 and CD8 expression [44].
As expected, compared to the wild-type ligand N4, higher
concentrations of T4 and V4 were needed to induce co-receptor
down-regulation but interestingly, identical dose-response curves
were obtained when non transgenic, TgLYPW or TgLYPWC227S
OT-1 thymocytes were exposed to the different peptides. We
concluded that expression of the two different forms of LYP does
not change antigen-sensitivity of OT-1 thymocytes (Fig. 5).
Next, we assessed the effect of the LYP-W620 transgene on
in vivo negative selection of polyclonal antigen-specific T cells using
a previously established Rip-mOva and Vb5 transgenic mouse
model system [45]. Vb5 mice express the same TCRb chain as
OT-1 T cells while they re-arrange endogenous TCRa chains
[46]. Fixing TCRb strongly elevates the frequency of Kb/Ova-
specific T cells; however, these T cells cover a wide range from low
to high avidity recognition for the Ova-antigen. Crossing Vb5 to
Rip-mOva mice causes the thymic deletion of high avidity Ova-
reactive T cells while low avidity T cells are spared [45]. Similar
results can be obtained when Vb5 bone marrow is transferred into
Rip-mOva hosts (DZ, unpublished observations). We asked
whether TgLYPW could modulate negative selection in Rip-
mOva mice and if this manipulation might lead to an escape of
higher affinity Vb5 T cells. Irradiated Rip-mOVA mice were
reconstituted with bone marrow from either non-Tg or TgLYPW
Vb5 mice. After infecting these bone marrow chimeric mice with
Listeria monocytogenes-Ova, we found that T cells with comparable
functional avidity for Kb/Ova could be found in non-Tg or
TgLYPW mice (Fig. 6A). Since higher avidity T cells normally
overgrow lower avidity T cell clones [43], we concluded from our
data that there is no change in the negative selection threshold
caused by the presence of human LYP-W620. We also assessed
whether LYP-W620 expression would result in enhanced expan-
sion of peripheral autoreactive T cell numbers that are normally
subject to negative selection in Rip-mOva mice. As previously
described, we applied two consecutive infections to expand low
avidity clones in Rip-mOva mice [47]. We observed that both
normal and LYPW Rip-mOva mice contained similar numbers of
low avidity Kb/Ova-reactive T cells (Fig. 6B). Together, the data
suggest that active LYP expression does not affect negative
selection of thymocytes or the frequency of autoreactive thymic
emigrants.
No Alterations of CD4+ Thymocyte Repertoire and
Severity of Arthritis in SkgxTgLYPW Mice
In order to assess the effect of LYPW overexpression on the
thymic repertoire of CD4+ T cells, we crossed TgLYPW mice with
Skg mice. Skg mice carry a mutation in Zap70 (W163C) that
attenuates T cell receptor signaling [35]. However, to some extent,
the reduced function Zap70 mutant can be compensated such that
CD4+ and CD8+ T cells can be found in the periphery of Skg
mice. Interestingly, a chronic form of arthritis develops spontane-
ously in these mice. Moreover, disease can be induced by injecting
fungal-derived polysaccharides into animals that are homozygous
for the Skg mutation and express at least one copy of the H2d
haplotype ( [35,39,40] and our unpublished data). It has also been
shown that Skg/Skg and heterozygote Skg/WT mice display
alterations in the Vb repertoire usage by CD4+Foxp32 thymocytes
and even more markedly in CD4+Foxp3+ thymocytes, which are
supposedly skewed toward a more self-reactive repertoire. These
alterations include decreased deletion of Vb3+ and Vb5+ T cells
and decreased positive selection of Vb8+ T cells [37]. Qualitatively
similar but quantitatively more marked alterations of the CD4+ Vb
repertoire, correlating with a more severe decrease in thymocyte
TCR signaling and thymocyte selection, were found in homozy-
gous Skg/Skg animals. Thus, we reasoned that Skg/WT and Skg/
Skg animals would be a sensitive model to detect subtle alterations
in CD4+ T cell selection caused by decreased thymocyte TCR
signaling [36,37]. Fig. 7A and 7B show that no alterations of the
frequencies of Vb3+, Vb5+, or Vb8+ thymocytes were found
among CD4+Foxp32 or CD4+Foxp3+ thymocytes in Skg/WT or
Skg/Skg TgLYPW mice versus non transgenic littermates,
suggesting that the decrease in TCR signaling caused by the
active phosphatase transgene is insufficient to cause significant
alterations in CD4+ T cell selection. Accordingly, the LYPW
transgene did not cause increased severity of mannan-induced
arthritis in Skg/Skg mice (Fig. 7C), and equal numbers of lymph
node Th17 cells were found in Skg/Skg TgLYPW and littermate
Skg/Skg mice one month after induction of arthritis by
intraperitoneal injection of mannan (Fig. 7C).
Discussion
With respect to genetic effect potency, the LYP-R620W
polymorphism currently ranks in second and third position,
respectively, as a risk factor for RA and for type 1 diabetes [2,48].
Although it is evident that the R620W variation is one of the
Table 1. Cell distribution in thymus of TgLYPW and
TgLYPWC227S.
TgLYPW
TgLYPW (n=5) Non Tg littermates (n=6)
Total thymocyte (x106) 127646.77 154632.21
DN 3.1261.97 2.4961.07
DP 75.1861.95 75.1365.25
CD4SP 13.261.84 13.4562.24
CD8SP 3.4560.8 3.760.69
CD252CD44+ % of DN 15.0463.59 18.2265.40
CD25+CD44+ % of DN 4.6862.05 4.5662.19
CD25+CD442 % of DN 42.1664.41 39.964.03
CD252CD442 % of DN 38.167.49 37.3563.63
NKT cells 1.360.19 1.3660.06
gammadelta T cells 0.2760.04 0.3160.03
TgLYPWC227S
TgLYPWC227S (n=5) Non Tg littermates (n=5)
Total thymocyte (x106) 160.78623.99 131.23621.36
DN 4.3262.51 3.5361.26
DP 71.7866.41 74.7862.37
CD4SP 17.7465.02 15.1862.51
CD8SP 4.1360.75 4.6060.73
CD252CD44+ % of DN 16.3269.46 17.1668.71
CD25+CD44+ % of DN 5.3161.65 4.5062.37
CD25+CD442 % of DN 41.9666.21 37.8063.33
CD252CD442 % of DN 37.0263.34 40.6065.95
Table shows the basic statistics (average6SD) of cell counts in transgenic
animals and non transgenic littermates.
doi:10.1371/journal.pone.0086677.t001
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Figure 3. No decrease in thymic output of Treg and positive or negative selection of HY-TCR-transgenic thymocytes in human LYP-
W620 transgenic (TgLYPW) and control mice. A, LYP-W620 overexpression does not alter the numbers of CD4+Foxp3+ thymocytes. Panel shows
% of GFP+ thymocytes among CD4SP from Foxp3-GFPxTgLYPW mice (black circles, n = 6) or non-Tg littermates (white circles, n = 3). B, No alterations
of positive selection of DO11.10+ thymocytes in TgLYPW mice. Panel shows numbers of DO11.10+ thymocytes in DO11.10xTgLYPWT mice or
DO11.10xTgLYPC227S mice (black circles and triangles, n = 4 and n= 3 respectively) or their respective non-Tg littermates (white circles and triangles,
n = 4 and n= 4 respectively). C, Overexpression of LYP does not alter negative selection in male F1 HY-TCRx.TgLYP mice. Upper left panel shows
numbers of HY-TCR+ thymocytes from male F1 HY.TgLYP mice (black circles, n = 7) or non-Tg littermates (white circles, n = 4). Upper right panel shows
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major non-HLA genetic risk factors for autoimmunity, its
mechanism of action at the molecular level and its role in the
immunopathogenesis of disease remain unclear.
Our experiments in primary T cells from type 1 diabetes
subjects and in Jurkat and primary human T cells overexpressing
LYPW lead us to propose a model that LYP-W620 acts as a gain-
of-function variant in phosphatase activity and in negative
regulation of TCR signaling [12]. Accordingly, an initial
hypothesis as to how the R620W variation might promote
autoimmunity was that variant LYP augments inhibition of
thymocyte TCR signaling and allows the escape of higher
numbers of auto-reactive T cells or of T cells exhibiting a higher
functional avidity (higher strength of self-pMHC and TCR
interaction) [12,49]. Since formulation of the hypothesis, addi-
tional data variably supporting a ‘‘gain-of-function’’[13,15–18],
‘‘loss-of-function’’ [20,21,50] or ‘‘altered-function’’ [23,24] phe-
notype of LYP-W620 in TCR signaling have been published.
Ptpn22-deficient mice exhibit abnormal accumulation of effec-
tor-like and memory T cells and heightened lymphoproliferation
capacity without clear-cut breaches in peripheral tolerance [9], but
Figure 4. No decrease in positive or negative selection of HY-TCR-transgenic thymocytes in human PTPN22 regulon transgenic
(BACLYPW) and control mice. A, Overexpression of LYP-W620 under control of the PTPN22 physiological promoter does not affect total
thymocyte number in BAC transgenic mice. Panel shows total numbers of thymocytes in BACLYPW mice (black circles, n = 6) or their respective non-
Tg littermates (white circles, n = 8). B–C, overexpression of LYP-W620 does not alter positive or negative selection and the subpopulation distribution
of HY-TCR+ thymocytes in BACLYPW mice. B, panel shows numbers of HY-TCR+ thymocytes from female HY-TCRxBACLYPW mice (black circles, n = 4)
or non-Tg littermates (white circles, n = 4). C, Left panel shows numbers of HY-TCR+ thymocytes from male HY-TCRxBACLYPW mice (black circles,
n = 8) or non-Tg littermates (white circles, n = 6). Right panel shows % of CD4SP, DP, CD8SP and DN thymocytes after gating on the HY+ population of
thymocytes from male HY-TCRxBACLYPW mice (black circles, n = 4) or non-Tg littermates (white circles, n = 4). Transversal bars in each panel indicate
mean value.
doi:10.1371/journal.pone.0086677.g004
% of CD4SP, DP, CD8SP and DN thymocytes after gating on the HY+ population of thymocytes from male HY-TCRxTgLYPW mice (black circles, n = 4)
or non-Tg littermates (white circles, n = 4). Bottom panels shows representative contour plot of CD4+ vs CD8+ expression of HY-TCR+ thymocytes from
HY-TCRxTgLYPW or non-Tg littermates. Transversal bars in each panel indicate mean value.
doi:10.1371/journal.pone.0086677.g003
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it has remained unclear whether these phenotypes solely relied on
a lack of peripheral or thymic Pep expression. Two independent
studies have found evidence of increased qualitative positive
thymocyte selection in Ptpn22 KO mice transgenic for the
D011.10 [9] and OT-II TCRs [10]. Another group recently
overexpressed WT Pep under control of the T lineage specific
distal Lck promoter [27], and found no alterations in thymocyte
subpopulation numbers in transgenic vs non transgenic mice.
However, based on the published Ptpn22 KO, knock-in, or
overexpression studies, no prediction could be made how a
presumed gain of function R620W variant of human LYP might
impact negative selection of auto-reactive T cells. Our study was
designed to test the hypothesis that the gain-of-function inhibition
of TCR signaling by LYP-W620 in thymocytes is sufficient to alter
thymic output in a manner that could increase predisposition to
autoimmunity. We studied the human phosphatase variant rather
than its mouse homolog W619 because it is currently unclear
whether regulation by Csk is conserved between the human and
mouse phosphatase, or whether the gain-of-function nature of the
R620W variant is fully replicated by the R619W mutation of
mouse Pep. To detect possible enzymatic activity-independent
effects of the phosphatase, we also generated animals transgenic
for the inactive C227S mutants of LYP-W620. In the presence of
LYP-W620, we observed increased phosphatase activity of LYP-
W620 in thymocytes, associated with decreased TCR signaling in
total thymocytes and DP thymocytes. No anomalies in thymic
TCR signaling were detected in animals carrying the inactive form
of LYP-W620, despite supraphysiological expression of LYP
directed by the transgene in these animals. Results with LYP-
W620 C227S variant-bearing mice thus suggest that effects of
phosphatase overexpression on thymocyte TCR signaling critically
depend upon enzymatic function of LYP.
Overexpression of active LYP-W620 did not lead to impaired
positive or negative selection of HY-TCR transgenic thymocytes
in male mice or in OT-1 TCR-transgenic thymocytes crossed to
Rip-mOva mice. Indeed, the finding of modestly-reduced
autoreactive thymocyte numbers in BACLYP (human PTPN22
promoter-driven) transgenic H-Y males suggests that LYP-W620
may actually promote negative selection of CD8+ T cells. Such a
phenotype is in line with the report by Dai et al., in which Pep-
W619-knockin autoreactive thymocytes exhibit augmented clonal
deletion [23]. We speculate that such subtle positive effects of
LYP-W620 on thymocyte selection are obliterated in our TgLYP
models by the combination of supraphysiological expression levels
and the use of an exogenous promoter.
Next, we considered the hypothesis that overexpression of the
LYP-W620 variant would only impact negative selection at an
intermediate TCR affinity range and thus might particularly
impact those clones bearing TCR with affinity for self-antigen
close to the threshold of negative selection. We addressed this
hypothesis by comparing the affinity of the bulk population of Kb/
Ova-reactive T cells that survive negative selection in Rip-mOva
mice. Normally, in such mice only T cells with low affinity for Kb/
Ova can be detected in the periphery [45]. We reasoned that if
LYP-W620 selectively reduces negative selection of T cells bearing
antigen receptors with affinity at or just above the threshold of
negative selection, then expression of TgLYPW would confer
increased in the overall functional avidity of Kb/Ova-reactive T
cells in Rip-mOva or Rip-mOvaxVb5 mice. Our negative data
clearly argue against this hypothesis.
We also considered whether LYP-W620 might selectively
impact CD4+ T cell selection. The pathogenesis of disease in
Skg mice depends on reduced TCR signaling in thymocytes,
which results in reduced positive and negative selection of CD4+
thymocytes, but the repertoire of Skg thymic emigrants contains T
cells with significant auto-reactive potential [36,37]. When we
overexpressed LYP-W620 in the thymus of Skg mice, we did not
observe alterations of CD4+ thymocyte repertoire or a gain in
disease severity. Higher affinity interactions with thymocyte TCR
by autoantigens are thought to be required for the differentiation
of Treg in the thymus, thus suggesting that alterations of TCR
signaling in the thymus might shape the amount and repertoire of
Treg [51]. However, we did not see changes in the output of
regulatory T cells from the TgLYPW Skg thymus, further arguing
against the notion that LYP-W620 selectively affects high-affinity
TCR interactions important for development.
Importantly, in the TgLYPW model, expression of the
transgene is controlled by the Lck proximal promoter and is only
expressed in the thymus but not in the periphery. Therefore, we
can exclude that we created a balanced situation such that we
might have augmented the thymic threshold but, at the same time,
caused similar increases in the peripheral T cell activation
threshold. Altogether, our observations imply that LYP-W620
does not have a major negative impact on selection of T cells in
general or on the threshold of negative selection in mice. This is
well in line with observations that complete absence of Pep had no
impact on negative selection [9].
Given the lack of impact on thymic selection, we suggest that
LYP-W620 might primarily act on peripheral T cells. A selective
effect of LYP-W620 on signaling in peripheral T cells would be
Figure 5. OT-1 thymocytes overexpressing LYP-W620 show similar antigen sensitivity as non-Tg thymocytes. Freshly isolated OT-1
transgenic thymocytes from TgLYP (black circles), TgLYPC227S (black triangles) or control non-Tg mice (white diamonds) were co-cultured overnight
together with RMA cells and the indicated doses of SIINFKL peptide (N4, left panel), of the low and very low affinity altered peptide ligands SIITFEKL
(T4, middle panel) and SIIVFEKL (V4, right panel). Graphs show normalized dose-response values of peptide concentration vs the fraction of maximum
numbers of residual DP (CD4 and CD8 bright) thymocytes.
doi:10.1371/journal.pone.0086677.g005
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consistent with the observed increase of effector/memory T cells
in Pep KO mice. However, a gain of function mutant that
increases the activation threshold of effector T cells is difficult to
reconcile with auto-immunity. We therefore consider that a
peripheral model of promoting auto-immunity through the LYP-
R620W mutation could involve an impaired Treg function.
However, others have not documented diminished Treg function
in 619W knock-in mice [23].
Our findings lead us to the conclusion that the mechanism by
which LYP-W620 impinges on the immunopathogenesis of T cell-
modulated human disease is still uncertain and does not involve
major effects on thymocyte-intrinsic processes that establish
central tolerance. LYP-W620 might involve yet unknown effects
on T cells or it might cause a rather subtle impact that we failed to
detect in our experimental systems. One study reported that
subjects carrying LYP-W620 have increased numbers of effector T
cells [15]. A recent report also suggests that the R620W variation
might have unknown ‘‘change-in-function’’ effects [24] on T cells.
The LYP-R620W variation might impact the function of other
cell types including B cells. It has been suggested that an increased
burden of autoreactive B cells –perhaps secondary to weakened B
cell negative selection– underlies the predisposition of LYP-W620-
carrying subjects to autoimmune diseases [52]. Zhang et al. found
increased activation of dendritic cells in mice carrying a Pep-
R619W knock-in mutation, suggesting that hyperactive myeloid
cells also might also contribute to the mechanism of action of the
autoimmune predisposing variant [21]. Notably, the complexity
and subtlety of LYP-W620 function in myeloid cells likely rivals
that of its action in lymphocytes. Our recent work revealed
selective loss of capacity to produce type 1 interferon among
Figure 6. Polyclonal thymocytes undergo similar levels of negative selection in the presence of absence of transgenic LYP-W620. A,
Lethally irradiated Rip-mOva mice (continuous graphs and black symbols) or C57BL/6 mice (dotted graphs and crossed symbols) were reconstituted
with bone marrow harvested from Vb5xLYPW (circles) or Vb5 control (diamonds) mice. 10 weeks after the reconstitution the mice were infected with
a strain of Listeria monocytogenes expressing Ovalbumin (Lm-Ova). Splenocytes were harvested at 8 days after the infection and briefly in vitro re-
stimulated with titrated doses of SIINFEKL peptide. Afterwards, the cells were intracellularly stained for IFNc. Peptide-dose response curves showing
the frequency of IFNc producing CD8+ T cells as fraction of maximum response are presented. B, TgLYPW, TgLYPC227S and control non-Tg mice
contain similar numbers of low avidity auto-reactive T cells. RipxTgLYPW (left panel, black circles), RipxTgLYPWC227S (right panel, black triangles) and
control Rip mice (left and right panels, black diamonds) were infected with Lm-Ova and 4 weeks later challenged by a strain of Vesicular stomatitis
virus expressing Ova (VSV-Ova). On day 6 after the primary (left side of each panel) or the secondary infection (right side of each panel) blood was
drawn from the mice and PBMC were briefly re-stimulated with SIINFEKL peptide. The number of IFNc producing CD8+ T cells was determined by
intracellular cytokine staining. Panels show the frequency of Ova-specific T cells.
doi:10.1371/journal.pone.0086677.g006
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Figure 7. LYPW overexpression does not alter thymic repertoire and autoimmune phenotype of Skg mice. A–B, Overexpression of
LYPW does not alter Vb repertoire or numbers of CD4+Foxp3+ thymocytes in Skg/WT or Skg/Skg mice. Left panel shows average and SE % Vb positive
CD4+Foxp3+ and CD4+Foxp32 thymocytes from Skg/WT (A) or Skg/Skg (B) TgLYPW (striped bars, n = 3 for Skg/WT and n=6 for Skg/Skg) and control
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dendritic cells derived from BACLYPW transgenic mice [31].
Such a myeloid cell defect could contribute to cell-extrinsic
aberrations in effector T cells responding to infection or
inflammation, yet be consistent with absence of a T cell
developmental phenotype for LYP-W620.
Our results are supported by experiments in two different
mouse transgenic systems and multiple monoclonal and polyclonal
TCR transgenic models. However, there are few limitations,
including 1) the use of an overexpression system, which is
amenable to positional effects, 3) although knock-down and
deletion experiments suggest that the function of the phosphatase
in TCR signaling is conserved in human and mouse cells, the
expression of a human phosphatase in a mouse context can be
viewed as another limitation of our model and 4) the use of hybrid
mouse strains in some experiments might have decreased the
sensitivity to small effects. Despite the above-mentioned limita-
tions, our data strongly suggest that the increased activity of LYP,
which –according to several groups– is conferred by the R620W
variation, is insufficient to cause anomalies in thymic selection that
could underlie the increased risk of autoimmunity conferred by
carriage of the variant. TgLYPW mice transgenic for the active
phosphatase variant carried an average calculated phosphatase
activity between those reported for heterozygous or homozygous
human carriers of the LYP-W620 variant. Since the overall
overexpression of the phosphatase was low, the most likely
explanation for the lack of a phenotype is that the decrease in
thymocyte TCR signaling caused by the overexpression of the
phosphatase was too small to significantly affect thymic selection.
An additional or alternative explanation to explain the lack of
phenotype in SkgxTgLYPW mice is that after the threshold of
signaling inhibition necessary to trigger thymic signaling anomalies
has been trespassed, quantitative reductions in signaling are
required in order to see further decreases of selection and an
increase in severity of arthritis. Since no studies to date have
uncovered profound effects of LYP-W620 on thymic selection, an
alternative explanation is that TCR signaling in thymocytes might
be controlled by multiple redundant phosphatases. LYP-depen-
dent effects might not be detectable in the presence of a dominant
regulator such as CD45, which plays a major role in both positive
and negative regulation of TCR signaling in double positive and
single positive thymocytes [53].
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